Systemic amyloidosis from A (AA) to T (ATTR): a review - Muchtar - - Journal of Internal Medicine - Wiley Online Library
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
From amyloid-β to receptor endocytosis | Nature Reviews Neuroscience
A new era for understanding amyloid structures and disease | Nature Reviews Molecular Cell Biology
Physiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity | IntechOpen
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology
Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease - Rao - 2020 - Aging Cell - Wiley Online Library
The amyloid hypothesis of Alzheimer's disease at 25 years | EMBO Molecular Medicine
Alzheimer's disease | Nature Reviews Disease Primers
Pathophysiology and treatment of systemic amyloidosis | Nature Reviews Nephrology
Nrn ad posters- nature
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology
Amyloid-β-independent regulators of tau pathology in Alzheimer disease | Nature Reviews Neuroscience
Frontiers | Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease | Neuroscience
The amyloid interactome: Exploring protein aggregation
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Biology of Amyloid: Structure, Function, and Regulation - ScienceDirect
Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease | Nature Reviews Neuroscience
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade - IOS Press
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain | Nature Reviews Neurology
